Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-04-30 | "Dr. Scheinberg... is currently the Vincent Astor Chair and Chairman of Molecular Pharmacology... Dr. Scheinberg holds an M.D. and a Ph.D. in Pharmacology and Experimental Therapeutics" |
| 2020-04-23 | "Dr. Scheinberg holds an M.D. and a Ph.D. in Pharmacology and Experimental Therapeutics from the Johns Hopkins University School of Medicine." |
| 2021-04-23 | "Dr. Scheinberg holds an M.D. and a Ph.D. in Pharmacology and Experimental Therapeutics... The Company believes Dr. Scheinberg’s experience... as well as his expertise as a leading academic oncologist... qualifies him to serve on our Board." |
| 2023-04-28 | "Dr. Scheinberg holds an M.D. and a Ph.D. in Pharmacology and Experimental Therapeutics from the Johns Hopkins University School of Medicine." |
| 2024-04-29 | "Dr. Scheinberg holds an M.D. and a Ph.D. in Pharmacology and Experimental Therapeutics" |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-09